HERC1 (HECT and RLD Domain Containing E3 Ubiquitin Protein Ligase 1) is a massive E3 ubiquitin ligase enzyme that plays critical roles in protein quality control, autophagy, DNA repair, and cellular signaling. The HERC1 gene (ENSG00000102786) is located on chromosome 15q22.31 and encodes a protein of 4,862 amino acids, making it one of the largest known E3 ubiquitin ligases in humans 1.
The HERC family consists of two members in mammals (HERC1 and HERC2), both characterized by having a HECT (Homologous to E6-AP C-terminus) domain responsible for ubiquitin ligase activity and an N-terminal RCC1-like domain (RLD) that mediates protein-protein interactions. HERC1 is ubiquitously expressed with particularly high levels in the brain, where it performs essential functions in neuronal protein homeostasis 2.
Given the critical importance of protein quality control in neurons—due to their post-mitotic nature and high metabolic activity—HERC1 dysfunction has been strongly implicated in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and various neurodevelopmental disorders. The accumulation of misfolded proteins into toxic aggregates is a hallmark of these diseases, and HERC1's role in ubiquitin-mediated degradation makes it a key player in preventing such pathology.
¶ Molecular Biology and Structure
The HERC1 gene spans approximately 46 kb of genomic DNA and comprises 54 exons. It encodes a protein of 4,862 amino acids with a molecular weight of approximately 532 kDa. The gene is located on chromosome 15q22.31, a region that has been implicated in various neurological disorders.
¶ Protein Domain Architecture
HERC1 contains several distinct functional domains:
-
RCC1-Like Domain (RLD) (N-terminal)
- Seven repeats of the RCC1 motif
- Mediates guanine nucleotide exchange
- Facilitates protein-protein interactions
- Required for proper subcellular localization
-
HECT Domain (C-terminal)
- Catalytic domain (~350 amino acids)
- Contains active site cysteine for ubiquitin thioester formation
- Transfers ubiquitin to substrate proteins
- Forms E3 ubiquitin ligase activity
-
Linker Regions
- Connect RLD and HECT domains
- Contain regulatory phosphorylation sites
- Flexible regions allowing domain rearrangements
-
Additional Functional Regions
- Multiple protein-binding motifs
- Nuclear localization signals
- Membrane association domains
The structure of HERC1 reveals:
- Extended, multi-domain architecture
- Catalytic HECT domain at C-terminus
- N-terminal RLD for substrate recruitment
- Flexible hinge regions for regulatory control
- Dimerization capability through HECT domain
HERC1 is a key component of the ubiquitin-proteasome system (UPS), which is the primary pathway for targeted protein degradation in eukaryotic cells. The UPS involves:
- Ubiquitin activation: E1 enzyme activates ubiquitin
- Ubiquitin transfer: E2 enzyme receives ubiquitin
- Ubiquitin ligation: E3 ligase (HERC1) transfers ubiquitin to substrate
- Proteasomal degradation: Polyubiquitinated proteins are degraded
HERC1 catalyzes the formation of ubiquitin chains on target proteins:
- K48-linked chains: Target for proteasomal degradation
- K63-linked chains: Non-degradative signaling roles
- Other linkages: Various cellular regulatory functions
Beyond the proteasome, HERC1 regulates autophagy—the lysosomal degradation pathway:
Autophagy initiation:
- HERC1 ubiquitinates mTOR pathway components
- Modulates AMPK signaling
- Controls autophagy initiation complexes
Autophagosome formation:
- Regulates Beclin-1 and PI3K complexes
- Controls LC3 lipidation
- Facilitates autophagosome nucleation
Cargo recognition:
- Modulates p62/SQSTM1 function
- Controls selective autophagy receptors
- Links ubiquitinated cargo to autophagosomes
HERC1 participates in DNA damage response:
- Checkpoint regulation: Controls cell cycle arrest
- DNA repair recruitment: Facilitates repair complex assembly
- Chromatin remodeling: Modulates accessibility
- Apoptosis regulation: Decisions between repair and cell death
In neurons, HERC1 regulates:
- Synaptic plasticity: Long-term potentiation and depression
- Protein trafficking: Synaptic vesicle proteins
- Receptor turnover: NMDA and AMPA receptor degradation
- Presynaptic function: Neurotransmitter release
HERC1 dysfunction is strongly implicated in AD pathogenesis through multiple mechanisms 3:
Amyloid metabolism:
- HERC1 regulates APP (Amyloid Precursor Protein) processing
- Affects amyloid-β production and clearance
- Linked to amyloid plaque formation
Tau pathology:
- HERC1 modulates tau phosphorylation
- Controls tau degradation pathways
- Associated with neurofibrillary tangles
Neuronal protein quality control:
- Impaired UPS in AD brains
- HERC1 downregulation contributes to accumulation
- Synergistic with other E3 ligase deficiencies
Therapeutic implications:
- Enhancing HERC1 activity may improve clearance
- Gene therapy approaches under investigation
- Small molecule activators in development
HERC1 contributes to PD through:
α-Synuclein metabolism:
- HERC1 regulates α-synuclein degradation
- Impaired clearance leads to Lewy body formation
- Autophagy enhancement may be therapeutic
Mitochondrial quality control:
- HERC1 modulates mitophagy
- PINK1/PARKIN pathway interactions
- Dopaminergic neuron vulnerability
LRRK2 interactions:
- HERC1 interacts with LRRK2 kinase
- Mutations in both proteins increase PD risk
- Common pathways in protein handling
HERC1 mutations cause:
- Neurodevelopmental delay: Cognitive impairment
- Motor dysfunction: Ataxia, movement disorders
- Seizures: Epileptic activity
- Dysmorphic features: Developmental anomalies
While primarily studied in neurodegeneration, HERC1 has roles in cancer:
- Altered expression in various tumors
- Cell cycle dysregulation
- DNA repair pathways
- Prognostic significance in some cancers
| Tissue |
Expression Level |
Primary Role |
| Brain |
Very High |
Neuronal protein quality control |
| Testis |
High |
Spermatogenesis |
| Lung |
Moderate |
Epithelial function |
| Liver |
Moderate |
Metabolic function |
| Heart |
Low-Moderate |
Cardiac function |
| Kidney |
Low |
Basic metabolism |
Within the brain, HERC1 shows highest expression in:
- Hippocampus: CA regions, dentate gyrus (memory)
- Cerebral cortex: All layers (cognitive function)
- Cerebellum: Purkinje cells (motor coordination)
- Basal ganglia: Striatum (movement control)
- Substantia nigra: Dopaminergic neurons
HERC1 localizes to:
- Cytoplasm: Primary location, diffuse distribution
- Nucleus: Nuclear envelope, some nuclear functions
- Endoplasmic reticulum: Membrane associations
- Synaptic terminals: Pre- and post-synaptic
- Axonal compartments: Transport vesicles
Therapeutic strategies targeting HERC1:
- UPS enhancers: Increase HERC1 expression/activity
- Autophagy inducers: Compensate for HERC1 deficits
- Combination therapy: HERC1 + other targets
Current approaches:
- Histone deacetylase (HDAC) inhibitors
- mTOR inhibitors (rapamycin, rapalogs)
- Natural compounds (resveratrol, curcumin)
HERC1-based PD therapies:
- α-Synuclein clearance enhancement
- Mitophagy restoration
- LRRK2 pathway modulation
Gene therapy approaches:
- AAV-mediated HERC1 delivery
- CRISPR-based correction
- Small molecule correctors
¶ Interactions and Pathways
HERC1 interacts with multiple proteins:
| Partner |
Interaction |
Functional Role |
| p62/SQSTM1 |
Direct binding |
Selective autophagy |
| AMPK |
Signaling |
Energy sensing |
| mTOR |
Signaling |
Growth control |
| p53 |
DNA damage |
Cell cycle |
| Beclin-1 |
Direct binding |
Autophagy initiation |
| LC3 |
Direct binding |
Autophagosome |
| Pathway |
HERC1 Role |
| mTOR |
Modulates activity |
| AMPK |
Energy stress response |
| p53 |
DNA damage response |
| NF-κB |
Inflammatory signaling |
| MAPK |
Stress response |
Key substrates for HERC1-mediated ubiquitination:
- mTOR complex components
- AMPK subunits
- p62/SQSTM1
- Various transcription factors
- Cell cycle regulators